136 related articles for article (PubMed ID: 30959254)
1. Efficacy and Safety of Hypofractionated Stereotactic Radiotherapy for Recurrent Malignant Gliomas: A Systematic Review and Meta-analysis.
Hu YJ; Chen D; Zhang LF; Chen J
World Neurosurg; 2019 Jul; 127():176-185. PubMed ID: 30959254
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated stereotactic radiotherapy combined with chemotherapy or not in the management of recurrent malignant gliomas: A systematic review and meta-analysis.
Hu YJ; Zhang LF; Ding C; Chen D; Chen J
Clin Neurol Neurosurg; 2019 Aug; 183():105401. PubMed ID: 31260910
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review.
Kulinich DP; Sheppard JP; Nguyen T; Kondajji AM; Unterberger A; Duong C; Enomoto A; Patel K; Yang I
Acta Neurochir (Wien); 2021 Jul; 163(7):1921-1934. PubMed ID: 33796887
[TBL] [Abstract][Full Text] [Related]
4. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
[TBL] [Abstract][Full Text] [Related]
5. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.
Vordermark D; Kölbl O; Ruprecht K; Vince GH; Bratengeier K; Flentje M
BMC Cancer; 2005 May; 5():55. PubMed ID: 15924621
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.
Reynaud T; Bertaut A; Farah W; Thibouw D; Crehange G; Truc G; Vulquin N
Technol Cancer Res Treat; 2018 Jan; 17():1533033818806498. PubMed ID: 30343637
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control.
Meniai-Merzouki F; Bernier-Chastagner V; Geffrelot J; Tresch E; Lacornerie T; Coche-Dequeant B; Lartigau E; Pasquier D
Sci Rep; 2018 Sep; 8(1):13666. PubMed ID: 30209337
[TBL] [Abstract][Full Text] [Related]
9. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of hypofractionated stereotactic radiotherapy for brain metastases using three fractions: A single-centre retrospective study.
Vigneau E; Jacquemin J; Benadon B; Dat Nguyen T; Marchand-Créty C
Cancer Radiother; 2021 Dec; 25(8):763-770. PubMed ID: 34083125
[TBL] [Abstract][Full Text] [Related]
11. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.
Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of hypofractionated stereotactic radiotherapy for tumors larger than 2 cm.
Koide Y; Tomita N; Adachi S; Tanaka H; Tachibana H; Kodaira T
Nagoya J Med Sci; 2019 Aug; 81(3):397-406. PubMed ID: 31579330
[TBL] [Abstract][Full Text] [Related]
13. Re-Irradiation with Stereotactic Radiosurgery/Radiotherapy for Recurrent High-Grade Gliomas: Improved Survival in the Modern Era.
Gigliotti MJ; Hasan S; Karlovits SM; Ranjan T; Wegner RE
Stereotact Funct Neurosurg; 2018; 96(5):289-295. PubMed ID: 30404102
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of Salvage Re-irradiation With Stereotactic Radiotherapy for Recurrent Glioma Using CyberKnife.
Adachi K; Hayashi K; Kagawa N; Kinoshita M; Sumida I; Akino Y; Shiomi H; Tamari K; Suzuki O; Hirayama R; Kijima N; Isohashi F; Seo Y; Otani K; Kishima H; Ogawa K
Anticancer Res; 2019 Jun; 39(6):2935-2940. PubMed ID: 31177132
[TBL] [Abstract][Full Text] [Related]
15. Survival and complications of stereotactic radiosurgery: A systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas.
Fetcko K; Lukas RV; Watson GA; Zhang L; Dey M
Medicine (Baltimore); 2017 Oct; 96(43):e8293. PubMed ID: 29068998
[TBL] [Abstract][Full Text] [Related]
16. Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma.
Ernst-Stecken A; Ganslandt O; Lambrecht U; Sauer R; Grabenbauer G
J Neurooncol; 2007 Feb; 81(3):287-94. PubMed ID: 17031558
[TBL] [Abstract][Full Text] [Related]
17. Hypofractionated reirradiation for recurrent malignant glioma.
Henke G; Paulsen F; Steinbach JP; Ganswindt U; Isijanov H; Kortmann RD; Bamberg M; Belka C
Strahlenther Onkol; 2009 Feb; 185(2):113-9. PubMed ID: 19240998
[TBL] [Abstract][Full Text] [Related]
18. Hypofractionated stereotactic radiotherapy for challenging brain metastases using 36 Gy in six fractions.
Dumont Lecomte D; Lequesne J; Geffrelot J; Lesueur P; Barraux V; Loiseau C; Lacroix J; Leconte A; Émery É; Thariat J; Stefan D
Cancer Radiother; 2019 Dec; 23(8):860-866. PubMed ID: 31677901
[TBL] [Abstract][Full Text] [Related]
19. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):293-8. PubMed ID: 10030252
[TBL] [Abstract][Full Text] [Related]
20. Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma.
Biau J; Chautard E; De Koning L; Court F; Pereira B; Verrelle P; Dutreix M
Radiat Oncol; 2017 Jul; 12(1):123. PubMed ID: 28754127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
